Generics

We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements 
of EDQM (CEP), ICH (ASMF in eCTD format), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.

Search for product

abcdefghijklmnoprstuvxyz

Filters

API Status

CommercialPipeline

Oncology

Alimentary tract & metabolismAntifungal agentAnti-infectives for systemic useAntipyretic, analgesic and anti-inflammatoryAntineoplastic & immunomodulating agentsBlood & blood forming organsCardiovascular systemGenito-urinary system & sex hormonesInjectable FormsMusculo-skeletal systemNervous systemOpthalmological preparationsRespiratory system

Available EU DMF/CEP/US DMF

Injectable Forms

Reset filters

API product & pipeline (pdf)

Sort by

Alphabetical Therapeutic Category

Sort:

Alphabetical Therapeutic Category

Status

Therapeutic Category

Polymorphic form

CAS No.

    E

  • Enzalutamide

    StatusPipeline

    Therapeutic CategoryOncology

    Polymorphic formAnhydrous form R1

    CAS No.915087-33-1

    View more